Cardiac Rhythm Management Device is a medical device which uses electrical impulses, delivered by electrodes contracting the heart muscles, to regulate the beating of the heart.

A cardiac rhythm management device (CRMD) refers to any permanently implanted cardiac pacemaker or any implantable cardioverter-defibrillator (ICD). The term CRMD also refers to any cardiac resynchronization device. The term CRT refers to a CRMD that provides cardiac resynchronization therapy using biventricular pacing techniques.
The classification of Pacemakers and Cardiac Resynchronization Therapy Device includes Pacemakers, ICD and CRT. And the proportion of Pacemakers in 2018 is about 47.8%. The ICD in 2018 is about 38.3%.Pacemakers and Cardiac Resynchronization Therapy Device is widely used in Bradycardia, Tachycardia, heart failure and other. Tachycardia and bradycardia are the most common indications for treatment, heart failure, diabetes and obesity can contribute to ongoing rhythm management concerns. And the market share used tachycardia in 2018 is 43%. And the market share used bradycardia in 2018 is 39%. North America is the largest consumption place, with a consumption market share nearly 48% in 2018. Following North America, Europe is the second largest consumption place with the consumption market share of 26.2%, Pacemakers and Cardiac Resynchronization Therapy Device market in Asia Pacific region is expected to exhibit the highest growth rate especially in the developing Asian countries like China & India.

Market Analysis and Insights: Global Pacemakers and Cardiac Resynchronization Therapy Devices Market
The global Pacemakers and Cardiac Resynchronization Therapy Devices market is valued at US$ 10650 million in 2019. The market size will reach US$ 13220 million by the end of 2026, growing at a CAGR of 3.1% during 2021-2026.

Global Pacemakers and Cardiac Resynchronization Therapy Devices Scope and Market Size
Pacemakers and Cardiac Resynchronization Therapy Devices market is segmented by Type, and by Application. Players, stakeholders, and other participants in the global Pacemakers and Cardiac Resynchronization Therapy Devices market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on sales, revenue and forecast by Type and by Application for the period 2016-2027.

Segment by Type
Pacemaker
ICD
CRT
In 2018, Pacemaker accounted for a major share of 47% in the global Pacemakers and Cardiac Resynchronization Therapy Devices market. And this product segment is poised to reach 736 K Units by 2025 from 670 K Units in 2019.

Segment by Application
Bradycardia
Tachycardia
Heart Failure
Others

By Company
Medtronic
St. Jude Medical (Abbott)
Boston Scientific
Biotronik
MicroPort
Medico
Lepu (Qinming Medical)
IMZ
Cardioelectronica
Pacetronix

By Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Indonesia
Thailand
Malaysia
Philippines
Vietnam
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia